The ‘National Vitamin-A Plus Campaign’ will be observed on June 18 across the country to feed vitamin-A Plus capsule to over 2.20 crore children aged between six months to 59 months to prevent childhood blindness and reduce child mortality. Under the campaign, around 25 lakh children aged between 6 months and 11 months will be given a blue colour capsule ...
Read More »Health
Human brain’s cerebellum affected more than other regions from Covid, study finds
The human brain’s cerebellum might be more vulnerable to Covid infections than other brain regions, a new study employing an innovated MRI technique has found. The study from Rotman Research Institute and Sunnybrook Hospital in Toronto, Canada, reinforces the idea that Covid can lead to changes in the brain, it said. The new imaging technique, called correlated diffusion imaging (CDI), ...
Read More »Hospital doctors in England stage 72-hour walkout
Hospital doctors in England begin a new 72-hour strike over pay on Wednesday, prompting warnings from health officials of huge disruption to patients and services. The latest walk-out by junior doctors — those below consultant level — starts at 7:00 am (0600 GMT) and is set to last until Saturday. The British Medical Association’s Junior Doctors Committee say medics have ...
Read More »Positive results for potential first chikungunya vaccine
French-Austrian drugmaker Valneva’s vaccine candidate against chikungunya, a mosquito-borne virus which causes occasional outbreaks across the world, showed promising results in a large new trial, a study said on Tuesday. While the results were hailed as good news in the fight against chikungunya, the trial was carried out on people in the United States where the virus is extremely rare, ...
Read More »Diabetes, weight loss drug may help cut alcohol dependence in half
Semaglutide, which is primarily a diabetes drug and has been recently approved for the treatment of obesity, can also help cut alcohol dependence in half, finds a study in mice. Semaglutide is a long-acting substance that only needs to be taken once a week. This is the first medication to act on the GLP-1 receptor that can be taken in ...
Read More »5 signs of a healthy menstrual cycle you shouldn’t ignore
A healthy menstrual cycle is not only indicative of good reproductive health but also reflects overall well-being. It is essential for women to pay attention to their menstrual cycles and understand what constitutes a healthy and normal period. By being aware of the signs of a healthy menstrual cycle, women can better monitor their reproductive health and seek medical attention ...
Read More »Cheap diabetes drug reduces risk of long Covid: study
People who took a cheap diabetes drug after testing positive for Covid-19 had a 40 percent lower risk of getting long Covid, a US-based study said Friday. The finding was hailed as a potential “landmark” in the fight against the still little-understood condition, which the World Health Organization estimates affects one in 10 people who get Covid. The study said ...
Read More »Lung cancer pill cuts down risk of death by half: Study
A once-daily pill halved people’s risk of dying from a common lung cancer when they took the drug after tumour-removal surgery, trial results from a global study show. The research, published recently in The New England Journal of Medicine, found that taking the drug osimertinib after surgery dramatically reduced the risk of patients dying by 51 per cent. The researchers ...
Read More »Employers should exercise caution when introducing peer recognition initiatives: Study
Employers are constantly looking for better and more innovative ways to acknowledge people in the workplace, especially in circumstances where change is frequent and fast-paced. According to recent research from the University of Waterloo, however, employee comparisons made possible by public peer recognition may lead to some workers feeling mistreated. “Employers have sought out various peer recognition systems in an ...
Read More »New lung cancer pill cuts risk of death by half
A new pill has shown promise of reducing the risk of death from lung cancer by half, according to results of a decade-long global clinical trial. Taking the drug osimertinib, developed by AstraZeneca, after surgery dramatically reduced the risk of patients dying by 51 per cent, showed results presented at the American Society of Clinical Oncology’s (Asco) annual meeting in ...
Read More »